Dentists in Cambria Heights, NY Accepting Medicare
2 Dentists found. Showing 1 - 2
 Dr. David Maurice Reid, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 21902 Linden Blvd, Cambria Heights, NY 11411 Phone: 718-978-5938 Fax: 718-297-1930 |
Dr. Keven Peter Jackson, DDS PC Dentist Medicare: Not Enrolled in Medicare Practice Location: 22516 Linden Blvd, Cambria Heights, NY 11411 Phone: 718-978-0226 Fax: 718-977-0281 |
News Archive
Oxford-AstraZeneca COVID-19 vaccine induces robust T cell-based immunity
A recent study conducted by an international team of scientists has revealed that the Oxford-AstraZeneca coronavirus disease 2019 (COVID-19) vaccine, AZD1222, is capable of inducing strong spike-specific CD4+ T cell helper type 1 (Th1) and CD8+ T-cell responses in vaccinated individuals. A detailed description of AZD1222-induced cellular immunity is currently available on the medRxiv* preprint server.
Residents of socioeconomically deprived regions suffer from diabetes and obesity
Living in a socioeconomically deprived region is a risk factor for being affected by diabetes mellitus and obesity. This holds true regardless of the individual social status of the inhabitants. This is the conclusion reached by scientists from the Institute of Health Economics and Health Care Management at the Helmholtz Zentrum München and the Department of Epidemiology and Health Monitoring at the Robert Koch Institute in Berlin.
Access Pharmaceuticals issued U.S. patent
This patent, entitled "O,O'-Amidomalonato and N,O-Amidomalonato Platinum Complexes" is one of a series of patents and patent applications owned by Access which provides intellectual property protection to ProLindac and related tumor-targeted platinum compounds.
Table-top solid-state laser system cuts brain tissue with unprecedented precision
Researchers from the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy (MBI) were involved in the development of a table-top solid-state laser system that could cut brain tissue with unprecedented precision. The achievement is a result of an interdisciplinary EU project that involved partners from seven European countries.
Study suggests neutralizing SARS-CoV-2 antibodies offer protection against reinfection
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
› Verified 8 days ago
Pharmacists
Clinical Social Workers
Occupational Therapists
Counselors
Psychologists
Dentists